Subscribe now to claim 30% off your annual subscription plan (discount ends on 31 March 2025, 11:59pm GMT-4) by entering promo code: AWSactivate2024Milestone
Health tech company that operated clinical laboratories, blood & medical tests.
Description
Theranos was a health tech company that operated clinical laboratories, blood & medical tests. Its concept centered around cheap blood tests that could be carried out quickly from just one drop of blood, a potentially revolutionary development within the healthcare industry.
Legal Name
Theranos
Former Legal Name(s)
-
Company Reputation
-
Entity Type
Private limited company
Ownership Status
-
Operational Status
Inactive
Founded Date
2003
Operational Duration
15 years
Shutdown Date
2018
Last Financing Round
Funding round
Total Raised
USD 1.37B
Last Financing Date
23 Dec 2017
No. of Funding Round(s)
10
No. of Investor(s)
1
No. of Employees
10 - 50
Total Revenue
-
Post-money Valuation
-
Market Capitalization
-
Stage of Development
Validation
Transactional Model Type
B2B
Defensibility Moats
Experience curve, Trade secrets,
City
Palo Alto
State/Province
California
Country
United States
Industry
Biotechnology
Categories
Health Diagnostics, Health Care Technology, Medical Tests,
Continously lied about Theranos' technology, in self-denial, and tried to cover up the truth
Theranos technology had errors and no responsibility was taken
Paid more attention to creating hype instead of reseach and development
Staff and board of directors were inexperienced
Employees' loyalty were demanded, if not, there would be harsh consequences
Theranos lab practices were awful.
Their technology failed to attract top-tier health investors.
Note: Direct competitors are defined by similarity score of more than 40%, while similar companies are defined by similarity score of less than 40%
No. | Image | Name | Similarity score | Description | Industry | Categories | Location | Ownership status | Entity type | Stage of development | Transactional model type | Defensibility moats | Last financing round | Total raised | Post-money valuation | Last financing date | No. of funding round(s) | No. of investors | Investors | Total revenue | Market capitalization | No. of investments | No. of acquisitions | No. of board seats taken | Competition | Management | No. of employees | Company reputation | Contact info | Operational status | Operational duration | Shutdown date | Founded date | Legal name | Former legal name(s) | Ticker |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
No. | Image | Name | Investor type | Description | Location | Preferred investment stage(s) | Stages invested in | Assets under management (AUM) | Investment range | Investment sweet spot | Preferred investment focus | Preferred investment geography | No. of investments | No. of lead investments | No. of follow-on investments | No. of co-investments | Portfolio companies | No. of exits | Total exit value | No. of failed investments | Loss on investments | No. of acquisitions | No. of board seats taken | No. of funds | Limited partners | Co-investors | No. of partners | Partners | No. of employees | Management | Board members | Founders | Investor reputation | Contact info | Entity type | Legal name | Former legal name(s) | Founded date | Ticker |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | DFJ | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
No. | Image | Name | Previous designation | Previous company | Previous biography | Previous profile type | Previous location | Experience | Education | Reputation | Current company | Current designation | Current biography | Current profile type | Current location | No. of investments | No. of exits | Total exit value | No. of board seats taken | Contact info |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | T. Peter L. Thomas | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | |
2. | Robert L. Shapiro | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | |
3. | Donald L. Lucas | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | |
4. | Channing L. Robertson | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | |
5. | Ramesh L. Balwani | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | |
6. | Elizabeth Holmes | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
No. | Financing date | Financing round | Total amount raised | Post-money valuation | Financial viability | Fundraising target amount | Remaining target amount | Financing type | No. of investors | Board seats | Lead investors | Entity type | Financing status |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | 23 Dec 2017 | Funding round | USD 100M | - | - | - | 1 | - | - | - | Completed | ||
2. | 25 May 2017 | Secondary Market | USD 582.20M | - | - | USD 582.20M | Equity, | 34 | 4 | - | - | Completed | |
3. | 1 Mar 2015 | Funding round | USD 348.5M | - | - | - | 8 | - | - | - | Completed | ||
4. | 1 Feb 2014 | Funding round | USD 198.9M | - | - | - | - | - | - | - | Completed | ||
5. | 9 Sep 2013 | Funding Round | USD 50M | - | - | - | 1 | - | - | - | Completed | ||
6. | 8 Jul 2010 | Private Equity Round | USD 45M | - | - | USD 100M | USD 55M | Equity, Option, Warrant or Other Right to Acquire Another Security, | 1 | 6 | - | - | Completed |
7. | 17 Nov 2006 | Series C | USD 28.5M | - | - | - | 4 | - | - | - | Completed | ||
8. | 21 Feb 2006 | Series B | USD 9.1M | - | - | - | 1 | - | - | - | Completed | ||
9. | 11 Feb 2005 | Series A | USD 5.8M | - | - | - | 1 | - | - | - | Completed | ||
10. | 15 Jun 2004 | Seed Round | USD 500K | - | - | - | 1 | - | - | - | Completed |